Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study.

Saved in:
Bibliographic Details
Title: Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study.
Authors: Moyle GJ; Chelsea and Westminster Hospital, HIV Clinic, London, United Kingdom. gm@moyleg.demon.co.uk, DeJesus E, Cahn P, Castillo SA, Zhao H, Gordon DN, Craig C, Scott TR
Corporate Authors: Ziagen Once-Daily in Antiretroviral Combination Therapy (CNA30021) Study Team
Source: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2005 Apr 01; Vol. 38 (4), pp. 417-25.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Print ISSN: 1525-4135 (Print) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1525-4135
DOI:10.1097/01.qai.0000147521.34369.c9